St. Jude Medical (STJ) Tops Q2 EPS by 2c

St. Jude Medical (NYSE: STJ) reported Q2 EPS of $1.02, $0.02 better than the analyst estimate of $1.00. Revenue for the quarter came in at $1.41 billion versus the consensus estimate of $1.39 billion.

St. Jude Medical sees Q3 2015 EPS of $0.96-$0.98, versus the consensus of $0.96.

St. Jude Medical sees FY2015 EPS of $3.96-$4.00, versus the consensus of $3.94.

For earnings history and earnings-related data on St. Jude Medical (STJ) click here.

You May Also Be Interested In

• RXO shares soar as C.H. Robinson announces $5.8B cash and stock buyout
• BofA starts bullish coverage on NKT on rising HVDC cable demand
• Reliance Steel & Aluminum (RS) PT Raised to $421 at KeyBanc